Diagnostic  competence of Swiss general practitioners in skin cancer

Nina Badertscher; Ralph P Braun; Ulrike Held; Reto Kofmehl; Oliver Senn; Günther FL Hofbauer; Pascal O Rossi; Michel JP Wensing; Thomas Rosemann; Ryan Tandjung

doi:10.4414/smw.2013.13834

Original article

Vol. 143 No. 3132 (2013)

Diagnostic competence of Swiss general practitioners in skin cancer

Nina Badertscher
Ralph P Braun
Ulrike Held
Reto Kofmehl
Oliver Senn
Günther FL Hofbauer
Pascal O Rossi
Michel JP Wensing
Thomas Rosemann
Ryan Tandjung

DOI: https://doi.org/10.4414/smw.2013.13834
Cite this as:: Swiss Med Wkly. 2013;143:w13834
Published: 28.07.2013

References

Bouchardy C, Lutz JM, Kühni C. Cancer in Switzerland. Situation and Development from 1983 up to 2007. http://www.nicer.org/Editor/files/Krebs_in_der_Schweiz_e_web.pdf. http://www.nicer.org/Editor/files/Krebs_in_der_Schweiz_e_web.pdf In.; 2011.
Lutz JM, Francisci S, Mugno E, Usel M, Pompe-Kirn V, Coebergh JW, Bieslka-Lasota M. Cancer prevalence in Central Europe: the EUROPREVAL Study. Ann Oncol. 2003;14(2):313–22.
de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004;40(16):2355–66.
de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107(1):119–26.
Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27(1):3–9.
Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012;167(5):1124–30.
Dummer R, Panizzon R, Bloch PH, Burg G. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology. 2005;210(1):39–44.
Dummer R, Guggenheim M, Arnold AW, Braun R, von Moos R. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly. 2011;141:w13320.
Switzerland - Statistics of Cancer Incidence [http://www.nicer.org/assets/files/statistics/i5y8409ch.pdf]
Reinau D, Meier C, Gerber N, Hofbauer GF, Surber C. Sun protective behaviour of primary and secondary school students in North-Western Switzerland. Swiss Med Wkly. 2012;142:w13520.
Gass R, Bopp M: [Mortality from malignant melanoma: epidemiological trends in Switzerland]. Praxis. (Bern 1994) 2005;94(34):1295–300.
Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jockel KH. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol. 2008;22(1):65–72.
Badertscher N, Rosemann T, Tandjung R, Braun RP. minSKIN does a multifaceted intervention improve the competence in the diagnosis of skin cancer by general practitioners? Study protocol for a randomised controlled trial. Trials. 2011;12:165.
[http://aerztestatistik.myfmh2.fmh.ch/]
Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. J Am Acad Dermatol. 2001;44(6):979–86.
De Gannes GC, Ip JL, Martinka M, Crawford RI, Rivers JK. Early detection of skin cancer by family physicians: A pilot project. J Cutan Med Surg. 2004;8(2):103–9.
Gerbert B, Bronstone A, Wolff M, Maurer T, Berger T, Pantilat S, McPhee SJ. Improving primary care residents’ proficiency in the diagnosis of skin cancer. J Gen Intern Med. 1998;13(2):91–7.
Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen. 1996;3(1):47–53.
Raasch BA, Hays R, Buettner PG: An educational intervention to improve diagnosis and management of suspicious skin lesions. J Contin Educ Health Prof. 2000;20(1):39–51.
Westerhoff K, McCarthy WH, Menzies SW. Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol. 2000;143(5):1016–20.
Youl PH, Raasch BA, Janda M, Aitken JF. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions. Clin Exp Dermatol. 2007;32(4):365–70.

How to Cite

1.

Badertscher N, Braun R, Held U, Kofmehl R, Senn O, Hofbauer G, Rossi P, Wensing M, Rosemann T, Tandjung R. Diagnostic competence of Swiss general practitioners in skin cancer. Swiss Med Wkly [Internet]. 2013 Jul. 28 [cited 2024 Nov. 8];143(3132):w13834. Available from: https://smw.ch/index.php/smw/article/view/1716

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Ellen Keizer, Linda Huibers, Morten Bondo Christensen, Oliver Senn, Impact of alternative healthcare plans on out-of-hours help-seeking intentions in Switzerland , Swiss Medical Weekly: Vol. 148 No. 4344 (2018)
Corinne Chmiel, Oliver Senn, Thomas Rosemann, Claudia Steurer-Stey, Reply , Swiss Medical Weekly: Vol. 143 No. 1920 (2013)
Corinne Chmiel, Irina Giewer, Anja Frei, Thomas Rosemann, Reply to Roswitha Koch et al. , Swiss Medical Weekly: Vol. 149 No. 0910 (2019)
Yael Rachamin, Rahel Meier, Thomas Rosemann, Stefan Langenegger, Stefan Markun, Author reply to technical comment on: Rachamin et al. Statin treatment and LDL target value achievement in Swiss general practice , Swiss Medical Weekly: Vol. 150 No. 4748 (2020)
Thomas Rosemann, Freedom of choice – always beneficial? , Swiss Medical Weekly: Vol. 141 No. 5152 (2011)
Tugba Erdil, Klaus Steigmiller, John Ethan Rampa, Martin Christmann, Ulrike Held, Hitendu Dave, Severity of native pulmonary annular hypoplasia and late outcomes of tetralogy of Fallot: retrospective cohort study , Swiss Medical Weekly: Vol. 154 No. 11 (2024)

<< < 1 2 3 4

[1] Bouchardy C, Lutz JM, Kühni C. Cancer in Switzerland. Situation and Development from 1983 up to 2007. http://www.nicer.org/Editor/files/Krebs_in_der_Schweiz_e_web.pdf. http://www.nicer.org/Editor/files/Krebs_in_der_Schweiz_e_web.pdf In.; 2011.

[2] Lutz JM, Francisci S, Mugno E, Usel M, Pompe-Kirn V, Coebergh JW, Bieslka-Lasota M. Cancer prevalence in Central Europe: the EUROPREVAL Study. Ann Oncol. 2003;14(2):313–22.

[3] de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004;40(16):2355–66.

[4] de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107(1):119–26.

[5] Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27(1):3–9.

[6] Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012;167(5):1124–30.

[7] Dummer R, Panizzon R, Bloch PH, Burg G. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology. 2005;210(1):39–44.

[8] Dummer R, Guggenheim M, Arnold AW, Braun R, von Moos R. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly. 2011;141:w13320.

[9] Switzerland - Statistics of Cancer Incidence [http://www.nicer.org/assets/files/statistics/i5y8409ch.pdf]

[10] Reinau D, Meier C, Gerber N, Hofbauer GF, Surber C. Sun protective behaviour of primary and secondary school students in North-Western Switzerland. Swiss Med Wkly. 2012;142:w13520.

[11] Gass R, Bopp M: [Mortality from malignant melanoma: epidemiological trends in Switzerland]. Praxis. (Bern 1994) 2005;94(34):1295–300.

[12] Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jockel KH. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol. 2008;22(1):65–72.

[13] Badertscher N, Rosemann T, Tandjung R, Braun RP. minSKIN does a multifaceted intervention improve the competence in the diagnosis of skin cancer by general practitioners? Study protocol for a randomised controlled trial. Trials. 2011;12:165.

[14] [http://aerztestatistik.myfmh2.fmh.ch/]

[15] Brochez L, Verhaeghe E, Bleyen L, Naeyaert JM. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. J Am Acad Dermatol. 2001;44(6):979–86.

[16] De Gannes GC, Ip JL, Martinka M, Crawford RI, Rivers JK. Early detection of skin cancer by family physicians: A pilot project. J Cutan Med Surg. 2004;8(2):103–9.

[17] Gerbert B, Bronstone A, Wolff M, Maurer T, Berger T, Pantilat S, McPhee SJ. Improving primary care residents’ proficiency in the diagnosis of skin cancer. J Gen Intern Med. 1998;13(2):91–7.

[18] Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen. 1996;3(1):47–53.

[19] Raasch BA, Hays R, Buettner PG: An educational intervention to improve diagnosis and management of suspicious skin lesions. J Contin Educ Health Prof. 2000;20(1):39–51.

[20] Westerhoff K, McCarthy WH, Menzies SW. Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol. 2000;143(5):1016–20.

[21] Youl PH, Raasch BA, Janda M, Aitken JF. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions. Clin Exp Dermatol. 2007;32(4):365–70.